Dexcom G6 Now Available for Eligible Medicare Customers*

The future of continuous glucose monitoring is here

Take Control

Take control with Dexcom G6 and stay one step ahead of diabetes. Receive high/low glucose alerts and alarms.

How it works

Monitor glucose activity in real-time with a small sensor, transmitter and a Dexcom Receiver. Receive glucose readings every 5 minutes.

Exceptional Accuracy

The Dexcom G6 features an overall MARD^†of 9.0%^1,2 and demonstrates consistent performance even when glucose levels may be rapidly falling or rising¹.

No calibration required

No need to calibrate with a blood glucose meter, eliminating the need for fingersticks.^‡

^{‡ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.}

Long-life sensor

Wearable for up to 10 days of use.

Acetaminophen-blocking

The Dexcom G6 sensor prevents clinically significant interference from acetaminophen.^§3

Simple sensor insertion with an auto-applicator^||

One-button push insertion.

Urgent low soon alert

Receive a 20-minute advance warning of a potential severe hypoglycemic event (55 mg/dL).

Two alert schedules

Alerts can be customized for two periods of time within 24 hours (e.g., day and night schedules).

Please fill out the information below to help us determine if the Dexcom CGM is right for you or your loved one. A customer service representative of Dexcom, or a service provider on behalf of Dexcom, may follow up with you to process a full insurance benefits check or to discuss other Dexcom products, services or programs, after reviewing your information.

All fields marked with an asterisk (*) are required.

Personal Information

This form is intended for patients who aren’t currently using Dexcom CGM and haven’t already placed an order for a Dexcom CGM. If you are a current customer looking for service or have questions, please click here.

Patient date of birth *

Therapy Coverage Information

We are not currently indicated for use in persons with gestational diabetes. Reset diabetes type.

I agree to Dexcom’s Terms of Use and Privacy Policy, and agree that Dexcom (or a service provider on behalf of Dexcom) may (1) use my information to communicate with me about Dexcom products, services and programs, or to provide me with information relating to my healthcare treatment, payment for healthcare, or other health information or care coordination services, in accordance with such terms; and (2) contact me at the phone number and email address set forth above, and use automatic dialing machines, automated, pre-recorded voice messages, and may send SMS/text messages. I understand that I may opt out at any time by texting “STOP” in return to a text or by calling Dexcom at 888-738-3646, and that my consent to this contact is not required for the purchase of Dexcom products or services. I understand that my service provider’s airtime, message and data rates may apply. In addition, I certify that I (i) am the patient referenced above or (ii) am the parent or legal guardian of the patient referenced above, and that I am at least eighteen (18) years of age. *

I also agree that Dexcom (and a service provider) may share my information with one of Dexcom's distributors that directly serve Medicare beneficiaries.

Have Questions?
Our customer support representatives are available to help answer your questions at 888-738-3646.

Who is covered under Medicare?

According to CMS, therapeutic CGM may be covered by Medicare when all of the following criteria are met:

The beneficiary has diabetes mellitus; and,
The beneficiary has been using a home blood glucose monitor (BGM) and performing frequent (four or more times a day) BGM testing; and,
The beneficiary is insulin-treated with 3 or more daily injections (MDI) of insulin or a continuous subcutaneous insulin infusion (CSII) pump; and,
The beneficiary's insulin treatment regimen requires frequent adjustments by the beneficiary on the basis of therapeutic CGM testing results.
Within six (6) months prior to ordering the CGM, the beneficiary had an in-person visit with the treating practitioner to evaluate their diabetes control and determine that the above criteria are met; and,
Every six (6) months following the initial prescription of the CGM, the beneficiary has an in-person visit with the treating practitioner to assess adherence to their CGM regimen and diabetes treatment plan.

In order to be included in this category, the system must be defined as therapeutic CGM, meaning you can make treatment decisions using the device.

* For a full description of Medicare coverage criteria, please visit here

^{*must meet Medicare eligibility coverage criteria}

† MARD is a statistical measure of accuracy

†† Separate Follow App required.

‡ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

§ G6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every 6 hours. Taking a higher dose may affect the G6 readings.

|| Data on file.

1 Dexcom G6 CGM System User Guide, 2019.

2 Shah V LL, Wadwa P, et al. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technology and Therapeutics. 2018;20(6).

3 Calhoun P, Johnson TK, Hughes J, Price D, Balo AK. Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. J Diabetes Sci Technol. 2018:1932296818755797.

BRIEF SAFETY STATEMENT Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

What is CGM?

CGM vs. BGM

MM: Benefits of CGM

Benefits of CGM

Customer Stories

Become a Dexcom Warrior

Advocacy Organizations

Contact Us

Dexcom G6 Now Available for Eligible Medicare Customers*

The future of continuous glucose monitoring is here

Take Control

How it works

Exceptional Accuracy

Features of the Dexcom G6

No calibration required

Long-life sensor

Acetaminophen-blocking

Simple sensor insertion with an auto-applicator^||

Urgent low soon alert

Two alert schedules

Take the next step with Dexcom

Personal Information

Therapy Coverage Information


	If you obtain an official Medicare Health Insurance card with a red, white and blue horizontal stripe at the top, please select "Medicare" as the Medicare Type.


	Your Medicare Insurance Member ID number, also known as the Medicare Beneficiary Identifier (MBI), contains eleven random letters and numbers. It shows on the red, white, and blue Medicare card. You can also find it on paperwork you receive from the Social Security Administration.

Dexcom G6 Now Available for Eligible Medicare Customers*

Take Control

How it works

Exceptional Accuracy

Features of the Dexcom G6

No calibration required

Long-life sensor

Acetaminophen-blocking

Simple sensor insertion with an auto-applicator||

Urgent low soon alert

Two alert schedules

Take the next step with Dexcom

Personal Information

Therapy Coverage Information

Simple sensor insertion with an auto-applicator^||